0001437749-19-024819.txt : 20191223
0001437749-19-024819.hdr.sgml : 20191223
20191223162956
ACCESSION NUMBER: 0001437749-19-024819
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191219
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fratamico Arthur
CENTRAL INDEX KEY: 0001598129
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55242
FILM NUMBER: 191306483
MAIL ADDRESS:
STREET 1: C/O FLEXION THERAPEUTICS, INC.
STREET 2: 10 MALL ROAD, SUITE 301
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sun BioPharma, Inc.
CENTRAL INDEX KEY: 0001029125
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870543922
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 712 VISTA BLVD #305
CITY: WACONIA
STATE: MN
ZIP: 55387
BUSINESS PHONE: 9524791196
MAIL ADDRESS:
STREET 1: 712 VISTA BLVD #305
CITY: WACONIA
STATE: MN
ZIP: 55387
FORMER COMPANY:
FORMER CONFORMED NAME: Cimarron Medical, Inc.
DATE OF NAME CHANGE: 20150602
FORMER COMPANY:
FORMER CONFORMED NAME: CIMARRON SOFTWARE INC
DATE OF NAME CHANGE: 19961217
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-12-19
0001029125
Sun BioPharma, Inc.
SNBP
0001598129
Fratamico Arthur
712 VISTA BLVD #305
WACONIA
MN
55387
1
Stock Option (right to buy)
3.70
2019-12-19
4
A
0
6500
0
A
2029-12-19
Common Stock
6500
6500
D
Stock Option (right to buy)
3.70
2019-12-19
4
A
0
26800
0
A
2029-12-19
Common Stock
26800
26800
D
Scheduled to become fully exercisable the day before the annual meeting of stockholders to be held in 2020.
Immediately exercisable as to 50% of the shares and scheduled to vest with respect to 25% of the shares on each of December 19, 2020 and December 19, 2021.
/s/ Joshua L. Colburn
2019-12-23